Arctic Bioscience AS (OSL:ABS) EV-to-EBIT : -4.35 (As of May. 06, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Arctic Bioscience AS EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Arctic Bioscience AS's Enterprise Value is kr193.49 Mil. Arctic Bioscience AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was kr-44.52 Mil. Therefore, Arctic Bioscience AS's EV-to-EBIT for today is -4.35.

The historical rank and industry rank for Arctic Bioscience AS's EV-to-EBIT or its related term are showing as below:

OSL:ABS' s EV-to-EBIT Range Over the Past 10 Years
Min: -32.92 Med: -3.86 Max: -1.18
Current: -4.35

During the past 6 years, the highest EV-to-EBIT of Arctic Bioscience AS was -1.18. The lowest was -32.92. And the median was -3.86.

OSL:ABS's EV-to-EBIT is ranked worse than
100% of 430 companies
in the Biotechnology industry
Industry Median: 9.055 vs OSL:ABS: -4.35

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Arctic Bioscience AS's Enterprise Value for the quarter that ended in Dec. 2023 was kr193.49 Mil. Arctic Bioscience AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was kr-44.52 Mil. Arctic Bioscience AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -23.01%.

Arctic Bioscience AS EV-to-EBIT Historical Data

The historical data trend for Arctic Bioscience AS's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arctic Bioscience AS EV-to-EBIT Chart

Arctic Bioscience AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-4.94

-4.28

-4.35

Arctic Bioscience AS Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial					-4.94	-	-4.28	-	-4.35

Competitive Comparison of Arctic Bioscience AS's EV-to-EBIT

For the Biotechnology subindustry, Arctic Bioscience AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arctic Bioscience AS's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arctic Bioscience AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Arctic Bioscience AS's EV-to-EBIT falls into.

Arctic Bioscience AS EV-to-EBIT Calculation

Arctic Bioscience AS's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	193.489	/	-44.522
	=	-4.35

Arctic Bioscience AS's current Enterprise Value is kr193.49 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Arctic Bioscience AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was kr-44.52 Mil.

Arctic Bioscience AS (OSL:ABS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Arctic Bioscience AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-44.522	/	193.4898
	=	-23.01 %

Arctic Bioscience AS's Enterprise Value for the quarter that ended in Dec. 2023 was kr193.49 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Arctic Bioscience AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was kr-44.52 Mil.

Arctic Bioscience AS EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Arctic Bioscience AS's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Arctic Bioscience AS (OSL:ABS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Industrivegen 42, Orsta, NOR, 6155

Website

https://www.arctic-bioscience.com

Arctic Bioscience AS is a Norwegian biotechnology company. The company is focused on developing products and solutions based on bioactive marine compounds. The product portfolio includes nutraceuticals and pharmaceuticals. It is currently developing a novel, cost-efficient oral treatment (HRO350) for mild-to-moderate psoriasis. Its nutraceutical products are sold globally to both B2C and B2B under the Romega brand.

Arctic Bioscience AS (OSL:ABS) Headlines

No Headlines